Status:
COMPLETED
Canadian Anticoagulant Percutaneous Coronary Intervention Registry
Lead Sponsor:
University of Alberta
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Advances in mechanical intervention (PCI) and anticoagulation therapy have been the cornerstone of treatment of patients with coronary artery disease. However, the large diversity of approaches to ant...
Eligibility Criteria
Inclusion
- 18 or more years of age.
- Undergoing PCI during treatment with LMWH
- Provision of written and informed consent
Exclusion
- Language, medical, or psychiatric barriers that preclude understanding of informed consent process.
- Patients in which the site investigator is unable to comply with completion of study documentation following PCI, i.e. patients with planned transfer to another hospital not participating in the registry.
- Enrollment in a clinical trial involving another anticoagulant agent.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
747 Patients enrolled
Trial Details
Trial ID
NCT00773006
Start Date
February 1 2008
End Date
September 1 2011
Last Update
October 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7